Biora Therapeutics Inc (BIOR) — Financial Flexibility Index

Latest as of September 2024: -0.07x

Biora Therapeutics Inc (BIOR) has a Financial Flexibility Index of -0.07x as of September 2024. Free cash flow of $-8.71 Million (operating CF $-8.73 Million minus capex $19.00K) represents 0% of total liabilities ($121.13 Million). Also explore net asset momentum of Biora Therapeutics Inc to track the company's year-over-year net asset growth rate.

Financial Flexibility Index

-0.07x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-8.71 Million
Operating CF − Capex

Total Liabilities

$121.13 Million
USD

Capital Expenditures

$19.00K
USD

Biora Therapeutics Inc Financial Flexibility Index (2018–2023)

Historical Financial Flexibility Index trend for Biora Therapeutics Inc across 6 annual periods. For the full cash flow conversion analysis, see BIOR cash flow conversion.

Annual Financial Flexibility Index for Biora Therapeutics Inc (2018–2023)

Year-by-year free cash flow to debt coverage for Biora Therapeutics Inc. Explore BIOR operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2023 -0.36x $-48.40 Million $-48.50 Million $132.64 Million ▲ +10.6%
2022 -0.41x $-63.62 Million $-64.42 Million $155.81 Million ▲ +52.5%
2021 -0.86x $-166.63 Million $-167.49 Million $193.81 Million ▼ -39.8%
2020 -0.62x $-160.80 Million $-165.74 Million $261.43 Million ▼ -11.5%
2019 -0.55x $-102.40 Million $-106.12 Million $185.60 Million ▼ -40.3%
2018 -0.39x $-60.29 Million $-65.13 Million $153.37 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities